About Santiago Lozano-Calderon, MD, PhD
Dr. Santiago Lozano specializes in the evaluation and treatment of primary benign and malignant tumors of bone and soft tissue, as well as metastatic bone disease. His practice involves clinical research evaluating treatment and outcomes in oncology patients.
Dr. Lozano is a board-certified orthopaedic oncology surgeon. He earned his MD from Pontificia Universidad Javeriana Medical School in Bogota, Colombia.
Following his MD, he earned his PhD from the University of Amsterdam in the Netherlands. He conducted his PhD thesis research with Dr. Jesse Jupiter and Dr. David Ring at Massachusetts General Hospital. Dr. Lozano then completed his Orthopaedic Surgery Residency at New York Medical College in Valhalla, New York. He also completed a fellowship in Orthopaedic Oncology at Massachusetts General Hospital.
Clinical Interests:
- Amputations
- Benign bone tumors
- Benign soft tissue tumors
- Bone cancer
- Bone infections
- Bone metastases
- Limb-sparing procedures
- Malignant bone tumors
- Malignant soft tissue tumors
- Metabolic bone disease
- Metastatic bone disease
- Multiple myeloma
- Sarcomas
Treats:
- Adult
Languages:
- Spanish
Locations
Orthopaedic Oncology Service | Centers for Sarcoma & Chordoma
55 Fruit Street
Yawkey Center for Outpatient Care
Suite 3B
Boston, MA 02114
Phone: 617-643-4947
Medical Education
- MD, Pontificia Universidad Javeriana Medical School
- PhD, University of Amsterdam
- Residency, New York Medical College
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Orthopaedic Surgery, American Board of Orthopaedic Surgery
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Lozano has a strong interest in clinical research in orthopaedic oncology. His academic practice involves multiple clinical studies evaluating particular neoplastic problems of osseous and connective tissue nature. His focus of research includes clinical outcomes after reconstructive oncologic surgery in the upper and lower extremities, oncologic problems in the upper extremity and functional outcomes after surgical treatment in patients with primary sarcomas of bone and soft-tissue, as well as metastatic bone disease.
In the video below, he discusses the latest innovations in treating bone cancer using patient profiling to develop more targeted treatment plans. You can read more about Dr. Lozano's research on Mass General's Advances in Motion website
Publications
-
See a complete list of my publications via the National Institutes of Health.
Recent publications:
- Hoffman BA, Sanford C Jr, Didier AJ, Lassiter E, Lozano-Calderon SA. Pediatric Axial Ewing Sarcoma: A Retrospective Population-Based Survival Analysis. J Am Acad Orthop Surg Glob Res Rev. 2024 Jul 17;8(7):e24.00130. doi: 10.5435/JAAOSGlobal-D-24-00130. PMID: 39024656; PMCID: PMC11257667.
- Hoftiezer YAJ, Lozano-Calder?n SA, Schreuder HWB, Ulrich DJO, van der Heijden EPA. Vascularized reconstruction following extremity sarcoma resection - More than just a means to close a wound. Eur J Surg Oncol. 2024 Jul 10:108537. doi: 10.1016/j.ejso.2024.108537. Epub ahead of print. PMID: 39004558.
- Rizk PA, Gonzalez MR, Galoaa BM, Girgis AG, Van Der Linden L, Chang CY, Lozano-Calderon SA. Machine Learning-Assisted Decision Making in Orthopaedic Oncology. JBJS Rev. 2024 Jul 11;12(7). doi: 10.2106/JBJS.RVW.24.00057. PMID: 38991098.
- Lozano-Calderon SA, Clunk MJ, Gonzalez MR, Sodhi A, Krueger RK, Gruender AC, Greenberg DD. Assessing Pain and Functional Outcomes of Percutaneous Stabilization of Metastatic Pelvic Lesions via Photodynamic Nails: A Bi-Institutional Investigation of Orthopaedic Outcomes. JB JS Open Access. 2024 Jul 10;9(3):e23.00148. doi: 10.2106/JBJS.OA.23.00148. PMID: 38988331; PMCID: PMC11233101.
- Lietz CE, Newman ET, Kelly AD, Xiang DH, Zhang Z, Ramavenkat N, Bowers JJ, Lozano-Calderon SA, Ebb DH, Raskin KA, Cote GM, Choy E, Nielsen GP, Vlachos IS, Haibe-Kains B, Spentzos D. A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics. medRxiv [Preprint]. 2024 Jun 20:2024.06.19.24309087. doi: 10.1101/2024.06.19.24309087. PMID: 38946948; PMCID: PMC11213079.